Sudbury-based healthtech startup Verv has secured $3.8 million CAD in seed funding from United Kingdom vitro diagnostics company Randox Laboratories.
Peter Fitzgerald, founder and managing director of Randox, will join Verv’s board of directors.
Founded in 2012 by Jeff Sutton, Verv is developing an at-home blood testing kit named Vi. With a finger prick of blood, Verv claims that its blood plasma separator provides the appropriate blood sample for analysis.
As reported by Northern Ontario Business, Verv conducted a consumer survey with more than a thousand respondents last spring that found people across the United States and Canada want the convenience, safety, and speed of at-home blood testing kits.
The survey reported that 66 percent of its respondents said they want to test their own blood from home, and that 69 percent said that the COVID-19 pandemic has made them more interested in managing their health from home using new services and technologies.